Fatma Ugur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fatma Ugur has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Ali Bülent Cengiz
Department of Pediatric Infectious Disease, Faculty of Medicine, Hacettepe University, Ankara, Türkiye
2 shared publications - Aylin Irmak Kuruc
Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey
2 shared publications - Emine Dilara Karatas
Department of Pediatric Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey
2 shared publications - Kubra Aykac
Department of Pediatric Infectious Disease, Faculty of Medicine, Hacettepe University, Ankara, Türkiye
2 shared publications - Osman Oguz Demir
Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey
2 shared publications - Yasemin Ozsurekci
Department of Pediatric Infectious Diseases, Hacettepe University, Ankara, Turkey
2 shared publications
Latest Publications
- Open Access
- 4 June 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 170, 108853
Respiratory viral infections and disease severity in hospitalized children: A preimmunoprophylaxis baseline study highlighting the role of human metapneumovirus
- 4 June 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 170, 108853
Open AccessRespiratory viral infections and disease severity in hospitalized children: A preimmunoprophylaxis baseline study highlighting the role of human metapneumovirus
- Open Access
- 24 April 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (5) , 296
Pediatric adenovirus infections: 10-year clinical spectrum and predictors of severe disease with emphasis on comorbidities and coinfections
Human adenoviruses (HAdVs) may cause and are responsible for a broad range of pediatric illnesses. Although several cases are self-limiting, certain children may develop complications requiring pediatric intensive care (PICU). To address the role of HAdVs in children, we aimed to characterize the 10-year clinical spectrum of pediatric HAdVs infections and to identify factors associated with hospitalization and severe disease. This retrospective observational cohort study analyzed the clinical course of children (< 18 years) with laboratory-confirmed HAdV infection episodes treated at a tertiary pediatric center between 2014 and 2024. Demographic features, comorbidities, laboratory results, respiratory support requirements, PICU, and clinical outcomes were collected. The severe outcome was defined as a composite endpoint including PICU admission, invasive mechanical ventilation, and/or 30-day mortality. A total of 877 HAdV infection episodes were included, whereas 276 (31.5%) of the patients were hospitalized. Among hospitalized patients, 32.2% required respiratory support, 18.8% required PICU care, and the 30-day mortality was 2.5%. Overall, 104 children (11.9%) developed severe disease. Underlying medical conditions were significantly more frequent among children with severe disease, while those without underlying disease were more common in the non-severe group (69.8% vs. 22.1%; p < 0.001). Viral coinfections were detected in 35.8% of patients but were not associated with increased hospitalization or severity. In multivariable analysis, male sex (OR 2.30, 95% CI 1.23–4.29; p = 0.009), neurologic disease (OR 2.12, 95% CI 1.01–4.42; p = 0.045), cardiac disease (OR 3.27, 95% CI 1.49–7.17; p = 0.003), and hematopoietic stem cell transplantation (HSCT) (OR 4.32, 95% CI 1.36–13.7; p = 0.013) were independently associated with severe outcome. Conclusion : Human adenovirus infection represents a notable clinical burden in children, with a considerable proportion requiring hospitalization and developing severe disease. Underlying neurologic and cardiac diseases, as well as HSCT, were key risk factors for severe outcome, whereas viral coinfections were common but not associated with worse clinical outcome. What is Known? • Human adenovirus (HAdV) infections are common in children and usually self-limiting but may lead to severe disease. • Underlying medical conditions and immunosuppression have been associated with worse clinical outcomes in pediatric HAdV infections. What is New? • Underlying neurologic disease, cardiac disease, and HSCT were identified as independent predictors of severe outcome. • The findings highlight that host-related factors rather than viral coinfection are the main aspects of disease severity.
- 24 April 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (5) , 296
Open AccessPediatric adenovirus infections: 10-year clinical spectrum and predictors of severe disease with emphasis on comorbidities and coinfections
Human adenoviruses (HAdVs) may cause and are responsible for a broad range of pediatric illnesses. Although several cases are self-limiting, certain children may develop complications requiring pediatric intensive care (PICU). To address the role of HAdVs in children, we aimed to characterize the 10-year clinical spectrum of pediatric HAdVs infections and to identify factors associated with hospitalization and severe disease. This retrospective observational cohort study analyzed the clinical course of children (< 18 years) with laboratory-confirmed HAdV infection episodes treated at a tertiary pediatric center between 2014 and 2024. Demographic features, comorbidities, laboratory results, respiratory support requirements, PICU, and clinical outcomes were collected. The severe outcome was defined as a composite endpoint including PICU admission, invasive mechanical ventilation, and/or 30-day mortality. A total of 877 HAdV infection episodes were included, whereas 276 (31.5%) of the patients were hospitalized. Among hospitalized patients, 32.2% required respiratory support, 18.8% required PICU care, and the 30-day mortality was 2.5%. Overall, 104 children (11.9%) developed severe disease. Underlying medical conditions were significantly more frequent among children with severe disease, while those without underlying disease were more common in the non-severe group (69.8% vs. 22.1%; p < 0.001). Viral coinfections were detected in 35.8% of patients but were not associated with increased hospitalization or severity. In multivariable analysis, male sex (OR 2.30, 95% CI 1.23–4.29; p = 0.009), neurologic disease (OR 2.12, 95% CI 1.01–4.42; p = 0.045), cardiac disease (OR 3.27, 95% CI 1.49–7.17; p = 0.003), and hematopoietic stem cell transplantation (HSCT) (OR 4.32, 95% CI 1.36–13.7; p = 0.013) were independently associated with severe outcome. Conclusion : Human adenovirus infection represents a notable clinical burden in children, with a considerable proportion requiring hospitalization and developing severe disease. Underlying neurologic and cardiac diseases, as well as HSCT, were key risk factors for severe outcome, whereas viral coinfections were common but not associated with worse clinical outcome. What is Known? • Human adenovirus (HAdV) infections are common in children and usually self-limiting but may lead to severe disease. • Underlying medical conditions and immunosuppression have been associated with worse clinical outcomes in pediatric HAdV infections. What is New? • Underlying neurologic disease, cardiac disease, and HSCT were identified as independent predictors of severe outcome. • The findings highlight that host-related factors rather than viral coinfection are the main aspects of disease severity.